Farringdon Capital, Ltd. Glaukos Corp Transaction History
Farringdon Capital, Ltd.
- $242 Billion
- Q4 2024
A detailed history of Farringdon Capital, Ltd. transactions in Glaukos Corp stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 1,627 shares of GKOS stock, worth $249,256. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,627Holding current value
$249,256% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
359Shares Held
49.7MCall Options Held
227KPut Options Held
444K-
Black Rock Inc. New York, NY8.04MShares$1.23 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$915 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$331 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$316 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$296 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.29B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...